No connection

Search Results

ABBV vs PARK

ABBV
AbbVie Inc.
NEUTRAL
Price
$219.26
Market Cap
$387.52B
Sector
Healthcare
AI Confidence
68%
PARK
Park Dental Partners, Inc.
NEUTRAL
Price
$18.02
Market Cap
$81.4M
Sector
Healthcare
AI Confidence
75%

Valuation

P/E Ratio
ABBV
163.63
PARK
--
Forward P/E
ABBV
15.42
PARK
13.65
P/B Ratio
ABBV
-146.66
PARK
3.51
P/S Ratio
ABBV
6.5
PARK
0.33
EV/EBITDA
ABBV
15.27
PARK
11.93

Profitability

Gross Margin
ABBV
71.46%
PARK
17.04%
Operating Margin
ABBV
35.5%
PARK
-13.4%
Profit Margin
ABBV
4.0%
PARK
-0.15%
ROE
ABBV
137.96%
PARK
-4.09%
ROA
ABBV
9.59%
PARK
0.15%

Growth

Revenue Growth
ABBV
9.1%
PARK
7.5%
Earnings Growth
ABBV
-88.7%
PARK
--

Financial Health

Debt/Equity
ABBV
--
PARK
2.77
Current Ratio
ABBV
0.72
PARK
1.06
Quick Ratio
ABBV
0.47
PARK
0.98

Dividends

Dividend Yield
ABBV
3.05%
PARK
--
Payout Ratio
ABBV
490.15%
PARK
0.0%

AI Verdict

ABBV NEUTRAL

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Strengths
High operating margin (35.50%) indicating strong pricing power and cost control
Consistent revenue growth (9.10% YoY) outpacing sector average
Strong track record of earnings surprises (22 out of 25 quarters beat estimates)
Risks
Extremely high P/E ratio (163.63) vs forward P/E (15.42), suggesting potential overvaluation on trailing basis
Earnings growth collapsing (YoY: -88.70%, Q/Q: -88.10%) indicating severe profitability deterioration
Unsustainable dividend payout ratio (490.15%) threatening dividend security
PARK NEUTRAL

PARK exhibits a weak fundamental profile, highlighted by a Piotroski F-Score of 3/9, indicating significant financial instability. While the company shows a very attractive Price/Sales ratio (0.33) and a massive recent earnings surprise (+385.7%), these are offset by a high Debt/Equity ratio of 2.77 and negative operating margins. The stock is currently a speculative play where strong analyst price targets ($22.75) clash with poor deterministic health scores. Overall, the valuation is low, but the underlying financial health is precarious.

Strengths
Very low Price/Sales ratio (0.33) suggesting potential undervaluation of revenue
Significant earnings beat in the most recent quarter (+385.7%)
Positive revenue growth (7.5% YoY)
Risks
Weak Piotroski F-Score (3/9) indicating poor financial health
High leverage with a Debt/Equity ratio of 2.77
Negative operating margin (-13.40%) and negative ROE (-4.09%)

Compare Another Pair

ABBV vs PARK: Head-to-Head Comparison

This page compares AbbVie Inc. (ABBV) and Park Dental Partners, Inc. (PARK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile